The ElectronsOnRun project addresses a critical need in sustainable pharmaceutical synthesis by developing an efficient, eco-friendly method for trifluoromethylating enamides—compounds essential for enhancing drug stability, bioavailability, and efficacy. Fluorinated molecules are highly valued in pharmaceuticals, as the introduction of fluorine atoms can significantly improve metabolic stability, enabling longer-lasting and more effective drugs. Traditional batch methods for achieving this transformation, however, rely on toxic reagents, metals, and complex purification, posing environmental and safety concerns.
ElectronsOnRun adopts a continuous-flow electrochemical microreactor to generate trifluoromethylated products without supporting electrolytes or additives, using electricity as a clean reagent. Electrochemistry is ideal for sustainable synthesis, providing precise control over reaction conditions and reducing waste. When paired with flow technology, these advantages are maximized: the high surface-area-to-volume ratio in a microflow cell enhances yield and selectivity, while continuous processing supports safer, scalable production with reduced material and energy consumption.
This innovative approach aligns with the European Union’s sustainability objectives and the Green Deal’s commitment to greener chemical production. By advancing electrochemical flow technology, ElectronsOnRun not only addresses pressing industrial and environmental needs in pharmaceutical synthesis but also lays the groundwork for broader applications of green chemistry and safer, sustainable manufacturing.